KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Current Leases (2019 - 2026)

Evolent Health has reported Current Leases over the past 7 years, most recently at $15.3 million for Q4 2025.

  • For Q4 2025, Current Leases fell 42.57% year-over-year to $15.3 million; the TTM value through Dec 2025 reached $15.3 million, down 42.57%, while the annual FY2025 figure was $15.3 million, 42.57% down from the prior year.
  • Current Leases for Q4 2025 was $15.3 million at Evolent Health, down from $17.9 million in the prior quarter.
  • Over five years, Current Leases peaked at $35.2 million in Q1 2025 and troughed at $4.6 million in Q1 2023.
  • A 5-year average of $11.7 million and a median of $7.2 million in 2021 define the central range for Current Leases.
  • Biggest five-year swings in Current Leases: crashed 52.03% in 2024 and later soared 294.72% in 2025.
  • Year by year, Current Leases stood at $7.1 million in 2021, then grew by 0.75% to $7.1 million in 2022, then surged by 36.73% to $9.7 million in 2023, then skyrocketed by 174.36% to $26.7 million in 2024, then crashed by 42.57% to $15.3 million in 2025.
  • Business Quant data shows Current Leases for EVH at $15.3 million in Q4 2025, $17.9 million in Q3 2025, and $24.2 million in Q2 2025.